{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:51:35Z","timestamp":1788259895034,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jiac.2018.08.004","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T09:45:15Z","timestamp":1536227115000},"page":"915-920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact of carbapenem versus non-carbapenem treatment on the rates of superinfection: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-8637","authenticated-orcid":false,"given":"Khalid","family":"Eljaaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushira A.","family":"Enani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-2235","authenticated-orcid":false,"given":"Jaffar A.","family":"Al-Tawfiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.08.004_bib1","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the infectious Diseases society of America and the society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.08.004_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jac\/dkx384","article-title":"Impact of requiring re-authorization of\u00a0restricted antibiotics on day three of therapy","volume":"73","author":"Eljaaly","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jiac.2018.08.004_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/430912","article-title":"Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials","volume":"41","author":"Bliziotis","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jiac.2018.08.004_bib4","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious Diseases society of America and the American thoracic society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.08.004_bib5","series-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","article-title":"Chapter 8: assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"issue":"1","key":"10.1016\/j.jiac.2018.08.004_bib6","first-page":"70","article-title":"Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia","volume":"13","author":"Lerma","year":"2001","journal-title":"J\u00a0Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2018.08.004_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/AAC.38.3.547","article-title":"Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group","volume":"38","author":"Fink","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.jiac.2018.08.004_bib8","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.rmed.2006.01.004","article-title":"Comparison of piperacillin\/tazobactam and imipenem\/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia","volume":"100","author":"Joshi","year":"2006","journal-title":"Respir Med"},{"issue":"10","key":"10.1016\/j.jiac.2018.08.004_bib9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/archsurg.1997.01430340040005","article-title":"Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial","volume":"132","author":"Polk","year":"1997","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.jiac.2018.08.004_bib10","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.01232-12","article-title":"Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia","volume":"57","author":"Ramirez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2018.08.004_bib11","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1086\/426192","article-title":"Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial","volume":"40","author":"Shorr","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jiac.2018.08.004_bib12","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00003246-199710000-00015","article-title":"Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group","volume":"25","author":"Sieger","year":"1997","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.jiac.2018.08.004_bib13","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1128\/AAC.47.11.3442-3447.2003","article-title":"Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study","volume":"47","author":"Zanetti","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jiac.2018.08.004_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","article-title":"Effect of antimicrobial agents on the ecological balance of human microflora","volume":"1","author":"Sullivan","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"s3","key":"10.1016\/j.jiac.2018.08.004_bib15","first-page":"12","article-title":"Carbapenems in serious infections: maximizing the power, minimizing resistance","volume":"5","author":"Masterton","year":"1999","journal-title":"Clin Microbiol Infect"},{"issue":"7441","key":"10.1016\/j.jiac.2018.08.004_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jiac.2018.08.004_bib17","first-page":"39","article-title":"Risk of superinfection related to antibiotic use. Are all antibiotics the same?","volume":"18","author":"Alvarez","year":"2005","journal-title":"Rev Esp Quimioter"},{"issue":"1","key":"10.1016\/j.jiac.2018.08.004_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13063-014-0541-9","article-title":"Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial","volume":"16","author":"Harris","year":"2015","journal-title":"Trials"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1830254X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1830254X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:58:24Z","timestamp":1761159504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X1830254X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1341321X1830254X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.08.004","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of carbapenem versus non-carbapenem treatment on the rates of superinfection: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}